Krystal Biotech Announces Home Dosing in B-VEC Open Label Extension Study

Go back to Krystal Biotech Announces Home Dosing in B-VEC Open Label Extension Study
(NASDAQ: KRYS) Delayed: 363.44 -2.37 (0.65%)
Previous Close $365.81    52 Week High
Open $361.94    52 Week Low
Day High $367.79    P/E N/A 
Day Low $353.49    EPS
Volume 378,812